
Obetosan 10mg Tablet
Marketer
Sanatra Health Care
Salt Composition
Obeticholic acid (10mg)
Overview Obetosan 10mg Tablet
Ursodeoxycholic acid (UDCA) 10mg tablets are indicated, either independently or as part of a combined treatment regimen, for primary biliary cholangitis. Its mechanism involves suppressing bile acid synthesis and enhancing their hepatic excretion, thereby lowering intrahepatic bile acid levels and mitigating their harmful consequences. UDCA 10mg tablets can be administered with or without food, consistently at equally spaced intervals as directed by your physician. Maintaining a regular daily schedule aids adherence. It's crucial to complete the prescribed course; discontinuation before completion is inadvisable. Frequently reported adverse effects include pruritus, lassitude, dermatitis, pharyngalgia, vertigo, constipation, arthralgia, atopic dermatitis, and thyroid dysfunction. If any side effect persists or worsens, consult your doctor. Prior to commencing treatment, disclose any pre-existing health conditions and all concurrent medications to your physician, as drug interactions are possible. Pregnant or breastfeeding individuals should seek medical counsel before using this medication.
Primary Ingredients of Obetosan 10mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Obetosan 10mg Tablet
Managing primary biliary cholangitis
Major Benefits of Obetosan 10mg Tablet:
Consume Obetosan 10mg tablets precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. While Obetosan 10mg can be administered with or without food, consistent daily timing is recommended for optimal results.
Common Side effects of Obetosan 10mg Tablet:
- Throat pain
- Itching
- Fatigue
- Abdominal discomfort
- Rash
- Joint pain
- Oropharyngeal pain
- Dizziness
- Constipation
- Peripheral edema
- Palpitations
- Fever
- Thyroid disorders
- Eczema
How to use Obetosan 10mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Obetosan 10mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Obetosan 10mg Tablet works:
Obetosan 10mg Tablets activate the Farnesoid X receptor (FXR), modulating bile acid production, lipid processing, and glucose control. By suppressing bile acid synthesis and boosting excretion, Obetosan 10mg Tablets diminish hepatic bile acid reserves, mitigating their harmful consequences. This mechanism contributes to enhanced liver health.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Obetosan 10mg Tablet is undetermined; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Obetosan 10mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Obetosan 10mg Tablet with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Obetosan 10mg Tablets is undetermined. Refrain from driving if concentration or reaction time is impaired.
KidneySAFE IF PRESCRIBED
The use of Obetosan 10mg tablets in individuals with kidney disease is likely safe. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
LiverCAUTION
For individuals with advanced liver impairment, the use of Obetosan 10mg Tablets requires careful monitoring. Dosage modification of Obetosan 10mg Tablets may be necessary. Physician consultation is recommended.
What if you forget to take Obetosan 10mg Tablet :
Omit any missed dose of Obetosan 10mg Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Obetosan 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Bile acid alcohols and their derivatives |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
